[1] |
Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(5): 700-713.
|
[2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
[3] |
郑南翔, 单廷. 胃癌根治术患者术后早期复发转移的相关危险因素[J]. 中国老年学杂志,2017, 37(17): 4301-4303.
|
[4] |
Kim S, Jeon T, Choi C, et al. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer[J]. J Mol Diagn, 2013, 15(5): 661-669.
|
[5] |
Zhang H, Li S, Yang J, et al. The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival[J]. Int J Clin Exp Med, 2015, 8(2): 2635-2641.
|
[6] |
Li Y, Yang Y, Lu M, et al. Predictive value of serum CEA, CA19-9 and CA72-4 in early diagnosis of recurrence after radical resection of gastric cancer[J]. Hepato-gastroenterology, 2011, 58(112): 2166-2170.
|
[7] |
杜春霞, 郭春光, 徐泉, 等. 胃癌术后辅助化疗患者的肿瘤复发特征分析[J]. 中华肿瘤杂志, 2015, 37(8): 622-627.
|
[8] |
李莹, 刘芬. 伊立替康联合顺铂化疗对进展期胃癌复治患者的疗效评价[J/CD].中华卫生应急电子杂志, 2017, 3(6): 343-347.
|
[9] |
Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Eur J Surg Oncol, 2014, 40(5): 584-591.
|
[10] |
Strong V, Wu A, Selby L, et al. Differences in gastric cancer survival between the U.S. and China[J]. J Surg Oncol, 2015, 112(1): 31-37.
|
[11] |
Hu Y, Pu Q, Cui B, et al. MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2[J]. Int J Clin Exp Pathol, 2015, 8(8): 8921-8928.
|
[12] |
Marano L, Boccardi V, Braccio B, et al. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study[J]. World J Surg Oncol, 2015, 13: 215.
|
[13] |
Gwak H, Lee J, Park S. Preliminary evaluation of clinical utility of CYFRA 21-1, CA72-4, NSE, CA19-9 and CEA in stomach cancer[J]. Asian Pac J Cancer Prev, 2014, 15(12): 4933-4938.
|
[14] |
Zhong W, Yu Z, Zhan J, et al. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer[J]. Pathol Oncol Res, 2015, 21(1): 83-95.
|
[15] |
Chen C, Chen Q, Zhao Q, et al. Value of combined detection of serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the diagnosis of gastric cancer[J]. Ann Clin Lab Sci, 2017, 47(3): 260-263.
|